MedPath

Betaxolol 0.5% versus Brimonidine 0.2% prophylactic effect on IOP elevation after Nd: YAG Laser posterior capsulotomy

Phase 3
Conditions
posterior capsule opacification.
Age-related cataract
Registration Number
IRCT20200901048577N1
Lead Sponsor
Semnan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

patients with PCO after cataract surgery
above 21 years old

Exclusion Criteria

Patients with glaucoma (or history of glaucoma surgery)
cup to disc ratio greater than 0.5
intraocular pressure greater than 21 mmHg
active uveitis
active ocular infection
pregnancy
unstable cardiovascular condition
severe asthma and lung disease
Taking systemic or topical alpha 2 agonists, prostaglandin analogues, parasymapathomimetics, beta-blockers, carbonic anhydrase inhibitors

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Intraocular pressure. Timepoint: 1 hour before laser application and 4 hours after that. Method of measurement: Goldmann Applanation tonometry.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath